Overview on effectiveness of erenumab, fremanezumab, and galcanezumab in reducing medication overuse headache in chronic migraine patients

被引：0
|
作者：
Marcella Curone
Vincenzo Tullo
Henri Albert Didier
Gennaro Bussone
机构：
[1] Casa Di Cura Privata del Policlinico Igea Headache Center,Dental and Oral Surgery, Headache and Facial Pain Center Fondazione
[2] IRCCS Ca’ Granda,undefined
[3] Ospedale Maggiore Policlinico,undefined
[4] University of Milan,undefined
来源：
Neurological Sciences | 2022年 / 43卷
关键词：
Chronic migraine; Medication overuse headache; Anti-CGRP antibodies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5759 / 5761
页数：2
相关论文
共 50 条
  • [1] Overview on effectiveness of erenumab, fremanezumab, and galcanezumab in reducing medication overuse headache in chronic migraine patients
    Curone, Marcella
    Tullo, Vincenzo
    Didier, Henri Albert
    Bussone, Gennaro
    [J]. NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5759 - 5761
  • [2] Effectiveness of erenumab in chronic migraine patients with associated medication overuse headache: a prospective observational study
    Curone, Marcella
    Tullo, Vincenzo
    Bussone, Gennaro
    [J]. NEUROLOGICAL SCIENCES, 2020, 41 (SUPPL 2) : 509 - 510
  • [3] Effectiveness of erenumab in chronic migraine patients with associated medication overuse headache: a prospective observational study
    Marcella Curone
    Vincenzo Tullo
    Gennaro Bussone
    [J]. Neurological Sciences, 2020, 41 : 509 - 510
  • [4] The impact of fremanezumab on medication overuse in patients with chronic migraine
    Silberstein, Stephen D.
    Ashina, Sait
    Katsarava, Zaza
    Bibeau, Kristen
    Seminerio, Michael J.
    Harlow, Danielle E.
    Cohen, Joshua M.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [5] The Impact of Fremanezumab on Medication Overuse in Patients with Chronic Migraine
    Silberstein, S. D.
    Ashina, S.
    Katsarava, Z.
    Bibeau, K.
    Seminerio, M. J.
    Harlow, D.
    Cohen, J. M.
    [J]. HEADACHE, 2018, 58 : 76 - 77
  • [6] The Impact of Fremanezumab on Medication Overuse in patients With Chronic Migraine
    Silberstein, Stephen
    Ashina, Sait
    Katsarava, Zaza
    Bibeau, Kristen
    Seminerio, Michael
    Harlow, Danielle
    Cohen, Joshua
    [J]. NEUROLOGY, 2019, 92 (15)
  • [7] The Impact of Fremanezumab on Medication Overuse in Patients with Chronic Migraine
    Silberstein, Stephen D.
    Cohen, Joshua M.
    Bibeau, Kristen
    Seminerio, Michael J.
    [J]. ANNALS OF NEUROLOGY, 2018, 84 : S84 - S85
  • [8] Effectiveness and safety of erenumab, galcanezumab and fremanezumab in migraine: real world data results
    Castano-Amores, C.
    Nieto-Gomez, P.
    Alvarez-Sanchez, R.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (03) : 819 - 820
  • [9] Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache
    Pensato, Umberto
    Baraldi, Carlo
    Favoni, Valentina
    Cainazzo, Maria Michela
    Torelli, Paola
    Querzani, Pietro
    Pascazio, Alessia
    Mascarella, Davide
    Matteo, Eleonora
    Quintana, Simone
    Asioli, Gian Maria
    Cortelli, Pietro
    Pierangeli, Giulia
    Guerzoni, Simona
    Cevoli, Sabina
    [J]. NEUROLOGICAL SCIENCES, 2022, 43 (02) : 1273 - 1280
  • [10] Multimorbidity in patients with chronic migraine and medication overuse headache
    D'Amico, Domenico
    Sansone, Emanuela
    Grazzi, Licia
    Giovannetti, Ambra M.
    Leonardi, Matilde
    Schiavolin, Silvia
    Raggi, Alberto
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2018, 138 (06): : 515 - 522
12345